Published in Int J Cardiol on December 01, 2001
Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J Am Heart Assoc (2012) 0.89
Microvascular angina due to microvascular coronary vasospasm. Int J Cardiol (2005) 0.75
MECHANISTIC INSIGHTS OF CORONARY VASOSPASM AND NEW THERAPEUTIC APPROACHES. Fukushima J Med Sci (2015) 0.75
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood (2001) 5.17
Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med (1993) 5.04
Angina pectoris caused by coronary microvascular spasm. Lancet (1998) 3.01
Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest (2000) 2.89
Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res (1999) 2.69
Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res (2001) 2.62
Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res (2000) 2.45
The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol (1996) 2.43
Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation (1994) 2.26
Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension (2001) 2.24
Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A (1999) 1.95
Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. Circulation (1997) 1.83
Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol (2000) 1.79
Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial injury. Circ Res (1992) 1.78
Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res (2000) 1.73
Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation (1996) 1.66
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia (1997) 1.66
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med (2000) 1.64
Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia. Leukemia (1998) 1.62
Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension (1998) 1.60
Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J (2001) 1.55
Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart (2005) 1.55
Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation (1994) 1.55
New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation (2001) 1.53
Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol (1996) 1.50
Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res (1999) 1.48
Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation (1993) 1.47
A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther (2000) 1.45
Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol (2000) 1.44
Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Cardiovasc Res (1999) 1.44
Transesophageal echocardiographic findings of quadricuspid aortic valve. Jpn Heart J (1991) 1.43
Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing. J Cardiovasc Pharmacol (2001) 1.43
Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation (1999) 1.42
Exogenous prostacyclin does not sensitize arterial baroreceptors. Am J Physiol (1991) 1.40
Use of pre-partum urine pH to predict the risk of milk fever in dairy cows. Vet J (2004) 1.39
Differentiation between aberrant ventricular conduction and ventricular ectopy in atrial fibrillation using RR interval scattergram. Circulation (1993) 1.39
Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Auris Nasus Larynx (2001) 1.36
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia (1998) 1.35
Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation (2000) 1.30
Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest (1997) 1.29
Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest (1993) 1.29
Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest (1997) 1.28
Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem (1999) 1.26
Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation (1987) 1.24
Cell cycle--dependent expression of L- and T-type Ca2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res (1996) 1.22
Role of nitric oxide towards vasodilator effects of substance P and ATP in human forearm vessels. Clin Sci (Lond) (1997) 1.22
Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest (1996) 1.20
Medical and socioenvironmental predictors of hospital readmission in patients with congestive heart failure. Am Heart J (2001) 1.20
Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J Biol Chem (1993) 1.19
Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol (2001) 1.18
Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod Pathol (2004) 1.18
Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum Mol Genet (2000) 1.17
Porphyromonas gingivalis fimbriae induce expression of the neutrophil chemotactic factor KC gene of mouse peritoneal macrophages: role of protein kinase C. Infect Immun (1992) 1.16
CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun (1996) 1.16
Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol (2001) 1.16
Thermostable farnesyl diphosphate synthase of Bacillus stearothermophilus: molecular cloning, sequence determination, overproduction, and purification. J Biochem (1993) 1.16
Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension (2001) 1.15
Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension (2001) 1.15
Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res (2001) 1.15
Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation (2000) 1.14
Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation (1994) 1.14
Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension (1999) 1.13
Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation (2000) 1.13
Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension (1998) 1.12
Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan. Jpn Circ J (2000) 1.11
Saccharomyces cerevisiae sigma 1278b has novel genes of the N-acetyltransferase gene superfamily required for L-proline analogue resistance. J Bacteriol (2000) 1.10
Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun (1993) 1.10
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol (1999) 1.09
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood (1997) 1.07
15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem (2001) 1.07
Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol (2000) 1.06
Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest (1992) 1.06
Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension (1995) 1.06
Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res (1990) 1.06
Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res (2001) 1.06
Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infect Immun (2000) 1.06
The Drosophila Bruton's tyrosine kinase (Btk) homolog is required for adult survival and male genital formation. Mol Cell Biol (1999) 1.06
Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation (2000) 1.05
Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol (2000) 1.04
Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension (1992) 1.04
Arrhythmia during insulin-induced hypoglycemia in a diabetic patient. Arch Intern Med (1984) 1.03
Involvement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. Blood (1991) 1.02
Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis (1997) 1.02
Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a familial predisposition to hypertension. Circ Res (1982) 1.00
Transcriptional regulation by transforming growth factor beta of the expression of retinoic acid and retinoid X receptor genes in osteoblastic cells is mediated through AP-1. J Biol Chem (1996) 1.00
Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res (1993) 0.99
Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol (2001) 0.99
Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol (1998) 0.99
A case of variant angina associated with eosinophilia. Am J Med (1989) 0.97
Dynamic effects of carotid sinus baroreflex on ventriculoarterial coupling studied in anesthetized dogs. Circ Res (1992) 0.97
Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation (2001) 0.97
Reduced baroreceptor sensitivity in borderline hypertension. Circulation (1975) 0.96
Phase I study of a novel recombinant human soluble thrombomodulin, ART-123. J Thromb Haemost (2004) 0.96
Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2001) 0.95